Earnings Recaps

Browse reported earnings of the most popular stocks

Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025 Sep 2, 2025 Sep 1, 2025 Aug 28, 2025 Aug 26, 2025 Aug 25, 2025 Aug 22, 2025 Aug 21, 2025 Aug 20, 2025 Aug 19, 2025 Aug 18, 2025 Aug 15, 2025 Aug 14, 2025 Aug 13, 2025 Aug 12, 2025 Aug 11, 2025 Aug 9, 2025 Aug 8, 2025 Aug 2, 2025 Aug 1, 2025 Jul 30, 2025 Jul 29, 2025 Jul 25, 2025
14 companies Today

Balchem Corporation

BCPC Q3 2025
Reported: 2025-10-21

Balchem Corporation reported a strong third quarter in 2025, achieving record sales and profitability across all segments, marking the 25th consecutive quarter of year-over-year adjusted EBITDA growth.

Key takeaways
  • Consolidated sales and adjusted EBITDA reached record levels, driven by robust demand in Human Nutrition and Health products.
  • Year-over-year growth was noted in all three reporting segments: Human Nutrition, Animal Nutrition and Health, and Specialty Products.
  • The company successfully managed to offset the impact of tariffs through strategic supply chain adjustments and pricing actions.
  • Balchem's scientific research initiatives continue to advance, with significant findings from the NIH-funded choline biomarker study promising to enhance the understanding of human choline deficiencies.
  • Ongoing investments in marketing capabilities, including the Real Science Exchange platform, are expanding brand reach and engagement within the industry.

Badger Meter, Inc.

BMI Q3 2025
Reported: 2025-10-21

Badger Meter reported robust Q3 2025 results, achieving 13% year-over-year sales growth and record free cash flows, driven by strong demand for its smart water management solutions despite ongoing economic challenges.

Key takeaways
  • Total sales reached $236 million, a 13% increase year-over-year with 8% base sales growth, supported by higher ultrasonic meter volumes.
  • Operating earnings rose 13% to $46.1 million, representing stable operating margins of 19.6%.
  • Gross margins improved to 40.7%, shifting the normalized range to 39%-42% in light of effective pricing strategies against cost pressures.
  • Record free cash flow of $48.2 million, driven by reduced cash taxes from recent tax law changes.
  • Confident outlook for continued high single-digit annual growth driven by ongoing demand for modular smart water solutions.

Crown Holdings, Inc.

CCK Q3 2025
Reported: 2025-10-21

Crown Holdings delivered strong third-quarter results, with earnings per share rising 13% year-over-year to $1.85, driven by increased segment income and robust cash flow from operational efficiencies.

Key takeaways
  • Adjusted EPS rose to $2.24, exceeding expectations and reflecting improved performance across various segments.
  • Net sales grew by 4.2%, supported by a 12% increase in European beverage shipments, despite challenges in Latin America.
  • Free cash flow improved significantly to $887 million year-to-date, with strategic share repurchases totaling $314 million and over $400 million returned to shareholders.
  • The company achieved its long-term net leverage target of 2.5 times, reinforcing its commitment to a strong balance sheet.
  • Full-year adjusted EPS guidance raised to $7.7 to $7.8, indicating continued confidence in performance despite market uncertainties.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...